Laboratorios Farmaceuticos Rovi, S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 151.18 million compared to EUR 201.63 million a year ago. Net income was EUR 14.96 million compared to EUR 47.46 million a year ago.
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
87.75 EUR | -0.28% | 88.28 | +0.60% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.76% | 4.94B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024